|Articles|January 1, 2019
- Pharmaceutical Executive-01-01-2019
- Volume 39
- Issue 1
Pharmaceutical Executive, January 2019 Issue (PDF)
Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Ipsen’s David Meek: Tasked to Transformalmost 7 years ago
Drug Research and Review Issues on Radar at FDAalmost 7 years ago
Finding the Right Digital Health Partneralmost 7 years ago
Future Pharma: Data Science as a Strategic Partneralmost 7 years ago
Ascending the Uncanny Valley in Healthcarealmost 7 years ago
Country Report: TurkeyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5
